GENSCI098
Clinical trials for GENSCI098 explained in plain language.
Never miss a new study
Get alerted when new GENSCI098 trials appear
Sign up with your email to follow new studies for GENSCI098, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test for new Graves' disease drug begins
Disease control Recruiting nowThis early-stage study is testing the safety of a new medication called GenSci098 for people with Graves' disease, an autoimmune condition that causes overactive thyroid. Researchers will give 24 participants increasing doses of the drug to check for side effects and see how the …
Matched conditions: GENSCI098
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
New eye disease drug enters human testing phase
Disease control Recruiting nowThis early-stage study aims to test the safety and side effects of a new injectable drug called GenSci098 in people with thyroid eye disease. Researchers will give increasing doses to 76 participants to see how their bodies handle the medication and monitor for any problems. The …
Matched conditions: GENSCI098
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC